Global Tumor Biomarker Test Market Size, Status and Forecast 2022

October 2017 | 102 pages | ID: G942D4D7C9BEN
QYResearch

Abstracts

This report studies the global Tumor Biomarker Test market, analyzes and researches the Tumor Biomarker Test development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Abbott Laboratories, Inc.
• Agilent Technologies
• AstraZeneca
• Becton Dickinson & Co.
• Biocept Inc.
• Cancer Genetics Inc.
• Danaher Corporation
• Foundation Medicine Inc.
• Illumina Inc.
• LabCorp Of America Holdings
• Luminex Corporation
• Myriad Genetics Inc.
• NanoString Technologies Inc.

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Prostate Specific Antigen Tests
• CTC Tests
• Alpha-Fetoprotein (AFP) Tests
• CA Test
• HER2 Tests
• BRCA Test
• Anaplastic Lymphoma Kinase (ALK) Tests
• EGFR Mutation Tests
• KRAS Test
• Others

Market segment by Application, Tumor Biomarker Test can be split into

• Lung cancer
• Breast cancer
• Colorectal
• Prostate Cancer
• Blood Cancer

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Tumor Biomarker Test Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF TUMOR BIOMARKER TEST

1.1 Tumor Biomarker Test Market Overview
  1.1.1 Tumor Biomarker Test Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Tumor Biomarker Test Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Tumor Biomarker Test Market by Type
  1.3.1 Prostate Specific Antigen Tests
  1.3.2 CTC Tests
  1.3.3 Alpha-Fetoprotein (AFP) Tests
  1.3.4 CA Test
  1.3.5 HER2 Tests
  1.3.6 BRCA Test
  1.3.7 Anaplastic Lymphoma Kinase (ALK) Tests
  1.3.8 EGFR Mutation Tests
  1.3.9 KRAS Test
  1.3.10 Others
1.4 Tumor Biomarker Test Market by End Users/Application
  1.4.1 Lung cancer
  1.4.2 Breast cancer
  1.4.3 Colorectal
  1.4.4 Prostate Cancer
  1.4.5 Blood Cancer

2 GLOBAL TUMOR BIOMARKER TEST COMPETITION ANALYSIS BY PLAYERS

2.1 Tumor Biomarker Test Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Abbott Laboratories, Inc.
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Tumor Biomarker Test Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Agilent Technologies
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Tumor Biomarker Test Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 AstraZeneca
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Tumor Biomarker Test Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Becton Dickinson & Co.
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Tumor Biomarker Test Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Biocept Inc.
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Tumor Biomarker Test Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Cancer Genetics Inc.
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Tumor Biomarker Test Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Danaher Corporation
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Tumor Biomarker Test Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Foundation Medicine Inc.
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Tumor Biomarker Test Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Illumina Inc.
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Tumor Biomarker Test Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 LabCorp Of America Holdings
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Tumor Biomarker Test Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Luminex Corporation
3.12 Myriad Genetics Inc.
3.13 NanoString Technologies Inc.

4 GLOBAL TUMOR BIOMARKER TEST MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Tumor Biomarker Test Market Size by Type (2012-2017)
4.2 Global Tumor Biomarker Test Market Size by Application (2012-2017)
4.3 Potential Application of Tumor Biomarker Test in Future
4.4 Top Consumer/End Users of Tumor Biomarker Test

5 UNITED STATES TUMOR BIOMARKER TEST DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Tumor Biomarker Test Market Size (2012-2017)
5.2 United States Tumor Biomarker Test Market Size and Market Share by Players (2016 and 2017)

6 EU TUMOR BIOMARKER TEST DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Tumor Biomarker Test Market Size (2012-2017)
6.2 EU Tumor Biomarker Test Market Size and Market Share by Players (2016 and 2017)

7 JAPAN TUMOR BIOMARKER TEST DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Tumor Biomarker Test Market Size (2012-2017)
7.2 Japan Tumor Biomarker Test Market Size and Market Share by Players (2016 and 2017)

8 CHINA TUMOR BIOMARKER TEST DEVELOPMENT STATUS AND OUTLOOK

8.1 China Tumor Biomarker Test Market Size (2012-2017)
8.2 China Tumor Biomarker Test Market Size and Market Share by Players (2016 and 2017)

9 INDIA TUMOR BIOMARKER TEST DEVELOPMENT STATUS AND OUTLOOK

9.1 India Tumor Biomarker Test Market Size (2012-2017)
9.2 India Tumor Biomarker Test Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA TUMOR BIOMARKER TEST DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Tumor Biomarker Test Market Size (2012-2017)
10.2 Southeast Asia Tumor Biomarker Test Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Tumor Biomarker Test Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Tumor Biomarker Test Revenue and Growth Rate (2017-2022)
  11.1.2 EU Tumor Biomarker Test Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Tumor Biomarker Test Revenue and Growth Rate (2017-2022)
  11.1.4 China Tumor Biomarker Test Revenue and Growth Rate (2017-2022)
  11.1.5 India Tumor Biomarker Test Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Tumor Biomarker Test Revenue and Growth Rate (2017-2022)
11.2 Global Tumor Biomarker Test Market Size (Value) by Type (2017-2022)
11.3 Global Tumor Biomarker Test Market Size by Application (2017-2022)

12 TUMOR BIOMARKER TEST MARKET DYNAMICS

12.1 Tumor Biomarker Test Market Opportunities
12.2 Tumor Biomarker Test Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Tumor Biomarker Test Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Tumor Biomarker Test Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Tumor Biomarker Test Product Scope
Figure Global Tumor Biomarker Test Market Size (Million USD) (2012-2017)
Table Global Tumor Biomarker Test Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Tumor Biomarker Test Market Share by Regions in 2016
Figure United States Tumor Biomarker Test Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Tumor Biomarker Test Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Tumor Biomarker Test Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Tumor Biomarker Test Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Tumor Biomarker Test Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Tumor Biomarker Test Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Tumor Biomarker Test Market Share by Type in 2016
Figure Prostate Specific Antigen Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure CTC Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure Alpha-Fetoprotein (AFP) Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure CA Test Market Size (Million USD) and Growth Rate (2012-2017)
Figure HER2 Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure BRCA Test Market Size (Million USD) and Growth Rate (2012-2017)
Figure Anaplastic Lymphoma Kinase (ALK) Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure EGFR Mutation Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure KRAS Test Market Size (Million USD) and Growth Rate (2012-2017)
Figure Others Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Tumor Biomarker Test Market Share by Application in 2016
Table Key Downstream Customer in Lung cancer
Figure Tumor Biomarker Test Market Size (Million USD) and Growth Rate in Lung cancer (2012-2017)
Table Key Downstream Customer in Breast cancer
Figure Tumor Biomarker Test Market Size (Million USD) and Growth Rate in Breast cancer (2012-2017)
Table Key Downstream Customer in Colorectal
Figure Tumor Biomarker Test Market Size (Million USD) and Growth Rate in Colorectal (2012-2017)
Table Key Downstream Customer in Prostate Cancer
Figure Tumor Biomarker Test Market Size (Million USD) and Growth Rate in Prostate Cancer (2012-2017)
Table Key Downstream Customer in Blood Cancer
Figure Tumor Biomarker Test Market Size (Million USD) and Growth Rate in Blood Cancer (2012-2017)
Table Tumor Biomarker Test Market Size (Million USD) by Players (2016 and 2017)
Figure Tumor Biomarker Test Market Size Share by Players in 2016
Figure Tumor Biomarker Test Market Size Share by Players in 2017
Table Abbott Laboratories, Inc. Basic Information List
Table Tumor Biomarker Test Business Revenue (Million USD) of Abbott Laboratories, Inc. (2012-2017)
Figure Abbott Laboratories, Inc. Tumor Biomarker Test Business Revenue Market Share in 2016
Table Agilent Technologies Basic Information List
Table Tumor Biomarker Test Business Revenue (Million USD) of Agilent Technologies (2012-2017)
Figure Agilent Technologies Tumor Biomarker Test Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Tumor Biomarker Test Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Tumor Biomarker Test Business Revenue Market Share in 2016
Table Becton Dickinson & Co. Basic Information List
Table Tumor Biomarker Test Business Revenue (Million USD) of Becton Dickinson & Co. (2012-2017)
Figure Becton Dickinson & Co. Tumor Biomarker Test Business Revenue Market Share in 2016
Table Biocept Inc. Basic Information List
Table Tumor Biomarker Test Business Revenue (Million USD) of Biocept Inc. (2012-2017)
Figure Biocept Inc. Tumor Biomarker Test Business Revenue Market Share in 2016
Table Cancer Genetics Inc. Basic Information List
Table Tumor Biomarker Test Business Revenue (Million USD) of Cancer Genetics Inc. (2012-2017)
Figure Cancer Genetics Inc. Tumor Biomarker Test Business Revenue Market Share in 2016
Table Danaher Corporation Basic Information List
Table Tumor Biomarker Test Business Revenue (Million USD) of Danaher Corporation (2012-2017)
Figure Danaher Corporation Tumor Biomarker Test Business Revenue Market Share in 2016
Table Foundation Medicine Inc. Basic Information List
Table Tumor Biomarker Test Business Revenue (Million USD) of Foundation Medicine Inc. (2012-2017)
Figure Foundation Medicine Inc. Tumor Biomarker Test Business Revenue Market Share in 2016
Table Illumina Inc. Basic Information List
Table Tumor Biomarker Test Business Revenue (Million USD) of Illumina Inc. (2012-2017)
Figure Illumina Inc. Tumor Biomarker Test Business Revenue Market Share in 2016
Table LabCorp Of America Holdings Basic Information List
Table Tumor Biomarker Test Business Revenue (Million USD) of LabCorp Of America Holdings (2012-2017)
Figure LabCorp Of America Holdings Tumor Biomarker Test Business Revenue Market Share in 2016
Table Luminex Corporation Basic Information List
Table Tumor Biomarker Test Business Revenue (Million USD) of Luminex Corporation (2012-2017)
Figure Luminex Corporation Tumor Biomarker Test Business Revenue Market Share in 2016
Table Myriad Genetics Inc. Basic Information List
Table Tumor Biomarker Test Business Revenue (Million USD) of Myriad Genetics Inc. (2012-2017)
Figure Myriad Genetics Inc. Tumor Biomarker Test Business Revenue Market Share in 2016
Table NanoString Technologies Inc. Basic Information List
Table Tumor Biomarker Test Business Revenue (Million USD) of NanoString Technologies Inc. (2012-2017)
Figure NanoString Technologies Inc. Tumor Biomarker Test Business Revenue Market Share in 2016
Table Global Tumor Biomarker Test Market Size (Million USD) by Type (2012-2017)
Figure Global Tumor Biomarker Test Market Size Share by Type in 2012
Figure Global Tumor Biomarker Test Market Size Share by Type in 2013
Figure Global Tumor Biomarker Test Market Size Share by Type in 2014
Figure Global Tumor Biomarker Test Market Size Share by Type in 2015
Figure Global Tumor Biomarker Test Market Size Share by Type in 2016
Figure Global Tumor Biomarker Test Market Size Share by Type in 2017
Table Global Tumor Biomarker Test Market Size (Million USD) by Application (2012-2017)
Figure Global Tumor Biomarker Test Market Size (Million USD) by Application in 2012
Figure Global Tumor Biomarker Test Market Size (Million USD) by Application in 2013
Figure Global Tumor Biomarker Test Market Size (Million USD) by Application in 2014
Figure Global Tumor Biomarker Test Market Size (Million USD) by Application in 2015
Figure Global Tumor Biomarker Test Market Size (Million USD) by Application in 2016
Figure Global Tumor Biomarker Test Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Tumor Biomarker Test
Figure United States Tumor Biomarker Test Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Tumor Biomarker Test Market Size (Million USD) by Players (2012-2017)
Figure United States Tumor Biomarker Test Market Size Share by Players in 2016
Figure United States Tumor Biomarker Test Market Size Share by Players in 2017
Figure EU Tumor Biomarker Test Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Tumor Biomarker Test Market Size (Million USD) by Players (2012-2017)
Figure EU Tumor Biomarker Test Market Size Share by Players in 2016
Figure EU Tumor Biomarker Test Market Size Share by Players in 2017
Figure Japan Tumor Biomarker Test Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Tumor Biomarker Test Market Size (Million USD) by Players (2012-2017)
Figure Japan Tumor Biomarker Test Market Size Share by Players in 2016
Figure Japan Tumor Biomarker Test Market Size Share by Players in 2017
Figure China Tumor Biomarker Test Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Tumor Biomarker Test Market Size (Million USD) by Players (2012-2017)
Figure China Tumor Biomarker Test Market Size Share by Players in 2016
Figure China Tumor Biomarker Test Market Size Share by Players in 2017
Figure India Tumor Biomarker Test Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Tumor Biomarker Test Market Size (Million USD) by Players (2012-2017)
Figure India Tumor Biomarker Test Market Size Share by Players in 2016
Figure India Tumor Biomarker Test Market Size Share by Players in 2017
Figure Southeast Asia Tumor Biomarker Test Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Tumor Biomarker Test Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Tumor Biomarker Test Market Size Share by Players in 2016
Figure Southeast Asia Tumor Biomarker Test Market Size Share by Players in 2017
Figure Global Tumor Biomarker Test Market Size (Million USD) by Regions (2017-2022)
Table Global Tumor Biomarker Test Market Size (Million USD) by Regions (2017-2022)
Figure Global Tumor Biomarker Test Market Size Share by Regions in 2017
Figure Global Tumor Biomarker Test Market Size Share by Regions in 2022
Figure United States Tumor Biomarker Test Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Tumor Biomarker Test Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Tumor Biomarker Test Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Tumor Biomarker Test Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Tumor Biomarker Test Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Tumor Biomarker Test Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Tumor Biomarker Test Market Size (Million USD) by Type (2017-2022)
Figure Global Tumor Biomarker Test Market Size Share by Type in 2017
Figure Global Tumor Biomarker Test Market Size Share by Type in 2022
Table Global Tumor Biomarker Test Market Size (Million USD) by Application (2017-2022)
Figure Global Tumor Biomarker Test Market Size (Million USD) by Application in 2017
Figure Global Tumor Biomarker Test Market Size (Million USD) by Application in 2022